MDT

86.38

+0.14%↑

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

PHR.US

9.06

+0.33%↑

MDT

86.38

+0.14%↑

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

PHR.US

9.06

+0.33%↑

MDT

86.38

+0.14%↑

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

PHR.US

9.06

+0.33%↑

MDT

86.38

+0.14%↑

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

PHR.US

9.06

+0.33%↑

MDT

86.38

+0.14%↑

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

PHR.US

9.06

+0.33%↑

Strona główna・Stock List・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Closed

SectorHealthcare

27.63 -0.22

Buy Sell

Overview

Share price change

24h

Current

Min

27.16

Max

27.78

Key metrics
By Trading Economics
Income	-28M 22M
Sales	4.3M 244M
P/E Sector Avg	10.225 66.418
Profit margin	9.224
Employees	293
EBITDA	-22M 52M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+48.86% upside

Dividends
By Dow Jones
Next Earnings	5 maj 2026

Market Stats
By TradingEconomics
Market Cap	55M 1.6B
Previous open	27.85
Previous close	27.63

News Sentiment

By Acuity

43%

57%

133 / 349 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

29.8 / N/A Support & Resistance

Harmony Biosciences Holdings Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

7 kwi 2026, 17:26 UTC

Major News Events

EIA Raises Oil-Price Forecasts as War in Middle East Continues

7 kwi 2026, 23:55 UTC

Market Talk

Genesis Energy Signals Higher Dividend Payout Ratios -- Market Talk

7 kwi 2026, 23:47 UTC

Market Talk

Major News Events

Market Talk Roundup: Latest on U.S. Politics

7 kwi 2026, 23:47 UTC

Market Talk

Major News Events

Precious Metals Rise, Boosted by Dollar Weakness, Lower Treasury Yields -- Market Talk

7 kwi 2026, 23:44 UTC

Market Talk

Major News Events

Gold Rallies as Trump Remarks Send Oil Prices Lower -- Market Talk

7 kwi 2026, 23:42 UTC

Market Talk

Global Equities Roundup: Market Talk

7 kwi 2026, 23:42 UTC

Market Talk

Nikkei Likely to Rise After Trump Agrees to Cease-Fire With Iran -- Market Talk

7 kwi 2026, 23:37 UTC

Market Talk

Major News Events

Oil Futures Fall After Trump Agrees to Two-Week Cease-Fire With Iran -- Market Talk

7 kwi 2026, 23:15 UTC

Market Talk

Major News Events

Markets Will Want Fast Evidence That Ships Are Moving -- Market Talk

7 kwi 2026, 23:04 UTC

Major News Events

Spot Gold Rises 2.5%, Spot Silver Climbs 4.9%

7 kwi 2026, 23:04 UTC

Major News Events

Precious Metals Rise After Trump Agrees to Ceasefire With Iran

7 kwi 2026, 23:03 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

7 kwi 2026, 23:03 UTC

Market Talk

Middle East Ceasefire Triggers Australian Dollar Rally -- Market Talk

7 kwi 2026, 23:01 UTC

Major News Events

Front-Month WTI Crude Oil Futures Falls 13.7% to $97.47 per Barrel

7 kwi 2026, 22:58 UTC

Major News Events

Front-Month Crude Oil Futures Slide After Trump Agrees to Cease-Fire With Iran

7 kwi 2026, 21:56 UTC

Acquisitions, Mergers, Takeovers

Telefónica Sells All Shares in Pegaso PCS, Celular de Telefonía

7 kwi 2026, 20:50 UTC

Market Talk

Major News Events

Basic Materials Roundup: Market Talk

7 kwi 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

7 kwi 2026, 19:45 UTC

Market Talk

Treasury Yields Mixed as Investors Brace for Iran Deadline -- Market Talk

7 kwi 2026, 19:17 UTC

Major News Events

The Risks to the Gulf Region's Oil Are Immense. Are Markets Shrugging Them Off? -- Barrons.com

7 kwi 2026, 19:16 UTC

Market Talk

Cold Shot Helps U.S. Natural Gas Futures Settle Higher -- Market Talk

7 kwi 2026, 19:07 UTC

Market Talk

Global Energy Roundup: Market Talk

7 kwi 2026, 19:07 UTC

Market Talk

Oil Futures Mixed Ahead of Trump's Iran Deadline -- Market Talk

7 kwi 2026, 18:41 UTC

Acquisitions, Mergers, Takeovers

Eldorado Gold: Total of 149.6M Common Shrs, Representing 75.31% of Votes Attached to All Outstanding Common Shrs, Were Voted >ELD.T

7 kwi 2026, 18:40 UTC

Acquisitions, Mergers, Takeovers

Eldorado Gold Holders Voted to Approve Issuance of Common Shrs in Connection With Proposed Plan of Arrangement With Foran Mining >ELD.T

7 kwi 2026, 18:39 UTC

Acquisitions, Mergers, Takeovers

Eldorado Gold Reports Voting Results From Special Meeting of Hldrs

7 kwi 2026, 18:24 UTC

Major News Events

Defense Stocks Can't Get a Boost From Iran War Escalations. What Would Move Them. -- Barrons.com

7 kwi 2026, 17:08 UTC

Market Talk

Latin America Less Exposed to Crude Supply Disruptions -- Market Talk

7 kwi 2026, 16:21 UTC

Major News Events

Defense Stocks Can't Get a Boost From Iran War Escalations. What Would Move Them. -- Barrons.com

7 kwi 2026, 16:20 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Health Care Roundup: Market Talk

Peer Comparison

Price change

Harmony Biosciences Holdings Inc Forecast

Price Target

By TipRanks

48.86% upside

12 Months Forecast

Average 41.25 USD 48.86%

High 62 USD

Low 25 USD

Based on 8 Wall Street analysts offering 12 month price targets forHarmony Biosciences Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

8 ratings

Buy

Hold

Sell

Based on 8 analysts giving stock ratings to Harmony Biosciences Holdings Inc - Dist in the past 3 months.

Technical Score

By Trading Central

29.8 / N/ASupport & Resistance

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

133 / 349 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.